# Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma

> **NCT00064220** · PHASE2 · COMPLETED · sponsor: **Daiichi Sankyo**

## Conditions studied

- Sarcoma

## Interventions

- **DRUG:** soblidotin

## Key facts

- **NCT ID:** NCT00064220
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2005-12
- **Final completion:** 2005-12
- **Target enrollment:** — (—)
- **Last updated:** 2012-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00064220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00064220, "Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00064220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*